Archive for the ‘Activism’ Category

Demystifying Lyme Detox – Dr. Rawls Webinar

https://rawlsmd.com/webinars/demystifying-lyme-detox/?

Join Dr. Bill Rawls for a live webinar on Wednesday, January 24th at 8PM (EST) as he shares his knowledge and research on the the myths and truths of Lyme Detox.

Topics include:

How toxins enter the body
Misconceptions about detoxification
Toxic and cleansing foods
Herbs to support detoxification>
And more!

As always, a live Q&A session with Dr. Rawls follows to answer your detox questions.

Reserve Your Seat Now »  https://rawlsmd.com/webinars/demystifying-lyme-detox/?

P.S. If you have any questions about the webinar call 800-951-2414.

 

 

Depression Not Caused by Chemical Imbalance

https://articles.mercola.com/sites/articles/archive/2018/01/18/chemical-imbalance-theory-for-depression.aspx?

Depression Not Caused by Chemical Imbalance  

depression

January 18, 2018

Story at-a-glance

  • Many people believe depression is caused by a chemical imbalance in the brain; this chemical imbalance theory has been widely promoted by drug companies and psychiatrists alike — without evidence to back it up
  • Pharmaceutical companies were instrumental in bringing the chemical imbalance theory to the mainstream, heavily promoting it as a marketing gimmick to sell antidepressant drugs
  • Studies have repeatedly shown antidepressants work no better than placebo for mild to moderate depression, yet carry a significant risk of side effects
  • Depression is likely the result of multiple environmental and biological factors, including faulty mood regulation by the brain, genetic vulnerability, stressful life events, nutrition, medications and medical problems, among others

By Dr. Mercola

Do you know what causes depression? Many people would respond that it’s due to a chemical imbalance in the brain. This chemical imbalance theory has been widely promoted by drug companies and psychiatrists alike, to the extent that it’s accepted as fact. The glaring problem is that the chemical imbalance theory is just that — a theory — and worse still, it’s a theory that has been largely discredited.

The theory was first proposed by scientists in the 1960s after it appeared certain antidepressant drugs worked by altering brain chemicals, but it was stated that “the findings are inconclusive.”1 Yet, the theory was proposed at a time when treating mental illness via psychoanalysis was falling out of favor while viewing it as tied to a physical or biological mechanism was in vogue.

The idea quickly spread, becoming the medical dogma for depression, despite concrete evidence proving its worth. “The fact that practicing physicians and leaders of science bought that idea, to me, is so disturbing,” Steve Hyman, director of the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard, told Quartz.2 The news outlet continued:

“It’s not hard to see why the theory caught on: It suited psychiatrists’ newfound attempt to create a system of mental health that mirrored diagnostic models used in other fields of medicine. The focus on a clear biological cause for depression gave practicing physicians an easily understandable theory to tell patients about how their disease was being treated.”3

Prozac, Zoloft Bring Chemical Imbalance Theory for Depression to the Mainstream

The release of the antidepressant Prozac (fluoxetine) in the late 1980s was a game changer for depression treatment in that the drug’s maker, Eli Lilly, heavily promoted the chemical balance theory as a marketing gimmick to sell the drug. With fewer side effects than some of the earlier antidepressants, Prozac became a blockbuster drug and the poster child for the selective serotonin reuptake inhibitor (SSRI) class of antidepressants, which target the neurotransmitter serotonin.

“There was, of course, no demonstrable evidence showing that depressed patients had any imbalance, but Lilly ran with it,” Psychology Today noted. “Before long, psychiatrists and psychiatric patients alike came to identify with the idea that mental disorders are caused by chemical imbalances in the brain.”4

Zoloft (sertraline), another SSRI, was another major player in spreading and perpetuating the chemical balance theory, with their television ads going so far as to say, “While the causes are unknown, depression may be related to an imbalance of natural chemicals between nerve cells in the brain. Prescription Zoloft works to correct this imbalance.”5

It’s important to note that in the time since Prozac flooded the market, depression still remains poorly treated, despite a plethora of new antidepressant options to choose from. SSRIs work by preventing the reuptake (movement back into the nerve endings) of the neurotransmitter serotonin.

This makes more serotonin available for use in your brain, which is thought to improve your mood since low serotonin levels are said to lead to depression. Yet, as written in the Handbook of Experimental Pharmacology, it’s a largely disproven theory:6

“Antidepressants are supposed to work by fixing a chemical imbalance, specifically, a lack of serotonin in the brain. Indeed their supposed effectiveness is the primary evidence for the chemical imbalance theory. But analyses of the published data and the unpublished data that were hidden by the drug companies reveal that most (if not all) of the benefits are due to the placebo effect.

Some antidepressants increase serotonin levels, some decrease it, and some have no effect at all on serotonin … The serotonin theory is as close to any theory in the history of science having been proved wrong.”

Harvard: Depression ‘More Complex’ Than a Brain Chemical Imbalance

It’s quite possible that people who are depressed may have an imbalance of certain chemicals in their brain. But to speculate that that imbalance is the cause of their symptoms is overly simplistic. For instance, it’s known that psychological stress can cause biological changes in the brain, including a reduction in the size of the hippocampus, which is used for learning and memory.7 In turn, it’s known that some people with depression have a smaller-than-average hippocampus.8

“Evidence of biological changes correlating with environmental stressors is vastly different from evidence that mental illnesses are ‘caused’ by biological deficits,” scientists wrote in a 2008 report on the chemical imbalance theory,9 and this is an important point. Even Harvard Medical School acknowledges that while brain chemicals may play a role in your mood, it is not accurate to suggest that one being too high or too low is at the root of depression. They state:10

“Research suggests that depression doesn’t spring from simply having too much or too little of certain brain chemicals. Rather, there are many possible causes of depression, including faulty mood regulation by the brain, genetic vulnerability, stressful life events, medications, and medical problems.

It’s believed that several of these forces interact to bring on depression … There are millions, even billions, of chemical reactions that make up the dynamic system that is responsible for your mood, perceptions, and how you experience life.”

One theory posits, for instance, that stress could be a major contributor to depression because it suppresses the production of new neurons in the hippocampus. In order to feel better, people with depression may need to increase neurogenesis (the generation of new neurons), which takes weeks.

This would explain why many people who take antidepressants don’t notice any improvement for several weeks.11 If the action was really on neurotransmitters, the patient should feel better right away when levels increase. Instead, triggering the growth of neurons could be the secret, which is a process that can be triggered naturally via exercise.

Believing Depression Is Caused by Chemical Imbalance Worsens Outcomes

Aside from the serious implications of prescribing drugs under a false premise, the chemical balance theory is also dangerous in that it takes away ownership from the patient. If a person feels a chemical imbalance in their brain is to blame for their depression, they may believe taking medications is the only option to feel better. According to Todd Kashdan, professor of psychology at George Mason University in Virginia, upon “buying into a biomedical explanation for their depression:”12

“They become pessimistic that recovery is possible. They become less confident that they can manage and regulate negative moods that arise (and they always do). The notion that depression is their brain’s fault does not lessen the stigma or self-blame one bit.

And they no longer believe that psychotherapy is a credible or useful strategy for treating their depression and instead, are ready to be dispensed a pill cure. Essentially, they become less flexible in their options for treating depression and less confident that they will escape its clutches.”

Indeed, a 2014 study published in Behavior Research and Therapy revealed just that — attributing depressive symptoms to a chemical imbalance made people more pessimistic about their prognosis and led them to believe that drugs would be more effective than psychotherapy.13 At the same time, they still felt the same amount of self-blame. It’s important to note that –

feeling depressed is not anyone’s fault, nor should they feel blamed for or ashamed of their feelings.

However, pinning its cause on a chemical imbalance is likely to worsen outcomes rather than improve them. It’s a vicious cycle as well, because the chemical imbalance theory makes people assume that medications are the best course of treatment. But here again research has shown that people with depression who are treated with medication have poorer long-term outcomes compared to those who are not.14

Antidepressants Work No Better Than Placebo

Nearly 7 percent of U.S adults suffered from a depressive episode in the past year15 while, worldwide, 350 million people suffer from depression, making it a leading cause of disability.16 Despite this, only about one-third of Americans with depression get treated,17 which puts the remaining two-thirds left untreated at increased risk of suicide and with a lower quality of life.

That said, the antidepressant drugs that are supposed to work by fixing a chemical imbalance in the brain are largely ineffective, which means that even when some people attempt to get treatment, they’re left suffering. Studies have repeatedly shown antidepressants work no better than placebo for mild to moderate depression.18

Irving Kirsch, associate director of the Program in Placebo Studies at Harvard Medical School, has conducted meta-analyses of antidepressants in comparison to placebo and has concluded that there’s virtually no difference in their effectiveness, noting, “The difference is so small, it’s not of any clinical importance.”19 What is different, however, is the potential for side effects, which is far greater among antidepressants than placebos.

For instance, antidepressant users have an increased risk of developing Type 2 diabetes,20 even after adjusting for other risk factors, like body mass index (BMI).21 Antidepressant use has also been linked to thicker arteries, which could contribute to the risk of heart disease and stroke.

The results of a study of 513 twin veterans, presented at the American College of Cardiology meeting in New Orleans in 2011, found that antidepressant use resulted in greater carotid intima-media thickness (the lining of the main arteries in your neck that feed blood to your brain).22

This was true both for SSRIs and antidepressants that affect other brain chemicals. Further, the use of antidepressants is also associated with an increased risk of heart attack, specifically for users of tricyclic antidepressants, who have a 36 percent increased risk of heart attack.23

Meanwhile, the drugs are also linked to dementia, with researchers noting “treatment with SSRIs, MAOIs, heterocyclic antidepressants, and other antidepressants was associated with an increased risk of dementia,” and as the dose increased, so too did the risk.24

The drugs are also known to deplete various nutrients from your body, including coenzyme Q10 and vitamin B12 — in the case of tricyclic antidepressants — which are needed for proper mitochondrial function. SSRIs may deplete iodine and folate,25 and you’re even more likely to relapse if you’re treated with antidepressants than if you’re treated via other methods, including placebo or exercise.26,27Given the lack of effectiveness and the risks involved, Kirsch and colleagues concluded:28

“When different treatments are equally effective, choice should be based on risk and harm, and of all of these treatments, antidepressant drugs are the riskiest and most harmful. If they are to be used at all, it should be as a last resort, when depression is extremely severe and all other treatment alternatives have been tried and failed.”

Alternative Treatments for Depression

If the chemical imbalance theory is false, the case for choosing antidepressants as a first-line treatment for depression is incredibly weak. Fortunately, there are many alternatives to drugs for treating depression, including nutritional interventions, light therapy, exercise and more. If you’re struggling with depression, you needn’t suffer in silence. Seek help, from a counselor, a holistic psychiatrist or another natural health practitioner to start the journey toward healing.

That said, if you are feeling desperate or have any thoughts of suicide, please call the National Suicide Prevention Lifeline, a toll-free number: 1-800-273-TALK (8255), call 911, or simply go to your nearest hospital emergency department. You cannot make long-term plans for lifestyle changes when you are in the middle of a crisis. If you’re in a place where you feel you can begin to make positive changes, here are some of the top alternative treatments for depression to consider:

Exercise. Those who didn’t exercise were 44 percent more likely to become depressed compared to those who did so for at least one to two hours a week.29
Light therapy. Light therapy alone and placebo were both more effective than Prozac for the treatment of moderate to severe depression in an eight-week-long study.30
Omega-3 fats, which have been shown to lead to improvements in major depressive disorder.31 Make sure you’re getting enough omega-3s in your diet, either from wild Alaskan salmon, sardines, herring, mackerel and anchovies, or a high-quality animal-based omega-3 supplement.
Optimize your vitamin D levels, another factor linked to depression32
Magnesium. Magnesium supplements led to improvements in mild-to-moderate depression in adults, with beneficial effects occurring within two weeks of treatment.33
B vitamins. Low levels of B vitamins are common in patients with depression, while vitamin B supplements have been shown to improve symptoms.34
Mindfulness meditation35 and the Emotional Freedom Techniques (EFT). In a study of 30 moderately to severely depressed college students, the depressed students were given four 90-minute EFT sessions. Students who received EFT showed significantly less depression than the control group when evaluated three weeks later.36
Cognitive behavioral therapy, which works as well as antidepressants and may reduce your risk of relapse even after it’s stopped.37
Limit sugar. Men consuming more than 67 grams of sugar per day were 23 percent more likely to develop anxiety or depression over the course of five years than those whose sugar consumption was less than 40 grams per day.38
 _____________
**Comment**
A very helpful article for Lyme/MSIDS patients as we nearly always at some point suffer with depression.  
Some of you might be on antidepressants and this article has left you floundering.  Take a deep breath and decide you are going to take this information, study it, and talk to your practitioner before deciding upon any course of action.
Please seek help if you need it.  If possible find at least a “Lyme friendly” practitioner as the last thing you need is to be abused by another health professional when you are at your lowest.  Hopefully the word is getting out on the psychiatric manifestations of Lyme/MSIDS.  Start by going to your local Lyme support group and ask around for a good, reputable, understanding, and hopefully experienced practitioner.
For those of you in the trenches, I want to encourage you that this too shall pass.  I found my depression while in treatment for Lyme/MSIDS was directly aligned to how I felt physically.  The worse I felt physically the worse I felt emotionally.  I’ve said this before, but the best advice I ever received from someone who made it to the other side of health was, “Don’t get depressed about feeling depressed.”  Give yourself permission to feel lousy.  Your body is in a battle of epic proportions – you’re bound to feel like crap.
Treating for Lyme/MSIDS is unlike most other treatments that have linear improvement.  You are going to have starts and stops, good days and bad, and down right horribly miserable days.  You are going to have days where you beg to have it all end.
Persevere.  Don’t quit.  Better days are coming.  Do not give in to the moment.  
When I got really low I read books where others had it worse than me.  I watched cartoons, anything to get my mind off the pain and hopelessness.  For a long time I didn’t read anything about treatment outcomes, because frankly I couldn’t have handled the truth.  That’s OK.  You don’t need to know how the watch works when you are at your lowest.  There will come a day when you can handle all that information, but for today, take a nice bath.  Listen to your favorite music.  Read your favorite books.  Call an understanding friend.  Whatever it takes to get through this day, minute, and second.

There has been researching showing that probiotics help with depression as well:  http://www.spring.org.uk/2017/03/probiotics-depression.phpThe scientists found that when mice in the study were put under stress, they developed a reduction in Lactobacillus through the metabolite kynurenine, which is somehow involved with inflammation and was linked to depressed behavior.  Feeding them Lactobacillus almost completely stopped their depressive behaviors.  

All Lyme/MSIDS patients should be on good pro and prebiotics and doing all they can to lower inflammation.  Read here about the microbiome and MSM’s ability to lower inflammation & help heal the gut:  https://madisonarealymesupportgroup.com/2018/01/03/the-invisible-universe-of-the-human-microbiome-msm/

If the depression hangs on, seek help.  Also, if you need to take medication short-term – so be it.  No judgement here.  We are all different and take different things to make it to the other side of health.  But, I encourage you to get to the bottom of things rather than mask it with a pill.  

My experience has shown me that treatment for pathogens is just one prong of our healing journey, and while important, isn’t the end-all.  We must detox.  We must address diet and sleep.  We must learn everything we can about our personal imbalances and weaknesses and seriously address them.  We must address our mental health and all that entails – from lowering our stress to ditching harmful relationships.
Thank you to all the mental health practitioners and patients out there writing about your experiences with Lyme/MSIDS psychiatric issues.  We need to hear what you have to say!

A Strange Itch, Trouble Breathing, Then Anaphylactic Shock

https://www.nytimes.com/2018/01/04/magazine/a-strange-itch-trouble-breathing-then-anaphylactic-shock.html?_r=1

A Strange Itch, Trouble Breathing, Then Anaphylactic Shock

By LISA SANDERS, M.D. JAN. 4, 2018

“I can’t breathe,” the woman panted, her voice a husky monotone. Her sister looked anxiously at the clerk at the triage desk at the University of Iowa hospital emergency room. The woman’s breath was rapid and coarse. Her chest heaved with the work of simply breathing. She pulled at the neck of her sweatshirt — suddenly it was too tight. She pulled it over her head and dropped it to the floor. She was naked beneath the top; she had been in bed when this attack came on.

The 54-year-old woman was helped into a wheelchair and whisked into the inner sanctum of the E.R. What followed was a blur of concerned faces, needles and medical data. Her blood pressure was dangerously low; her heart was racing. She was given epinephrine and steroids, but it was hours before she could explain what had happened that night.

She was staying at her mother’s house in rural Iowa, she told the doctors. Just as she was going to bed, she felt a sudden tingling in the palms of her hands. She recognized the sensation immediately: Twice in the past eight years, she had felt the same strange itch on her hands and sometimes her feet. Each time it was quickly followed by a terrifying sense of her throat closing.

Anaphylactic Shock

She had driven herself to her sister’s house, several miles away, and her sister drove her the rest of the way to the hospital. She opened the car window to let in the frigid winter night air. She struggled to breathe. Black spots swam before her eyes, but she willed herself not to pass out.

She had had this kind of allergic reaction twice before but never as severely. She knew from her own research that this was anaphylactic shock — a potentially deadly allergic reaction. After she got the medications, the woman’s symptoms resolved. She stayed in the hospital overnight, and when it was clear that the episode was over, she went back to her mother’s house. She made an appointment to see a local allergy specialist right away.

A Mystified Allergist

The specialist spent nearly two hours going over everything the woman had been exposed to — food, plants, toxins, anything that might have triggered this nearly fatal allergic reaction. There were no new exposures that day, nothing she hadn’t eaten or touched many times before and after this latest attack. The most common cause of severe allergic reactions in adults is food, but the allergist couldn’t identify any likely suspects. He was mystified. He asked her to share her diagnosis when she got one.

For months after returning to her home on Long Island, the woman was anxious about everything she ate, and she worried every night when she went to bed. She always kept a bottle of Benadryl and an EpiPen with her, but still she was terrified about what might happen if she was too far from a hospital the next time.

‘I Need a Nurse!’

When her next attack happened — just 10 months later — she was already in Brookhaven Memorial Hospital in East Patchogue, N.Y. She was being treated with antibiotics for a devastating case of gastroenteritis due to salmonella. Her first meal, after days of nothing but clear liquids, was beef brisket with potatoes and carrots. It smelled good, but she had no appetite. She made herself eat a few bites anyway, knowing it was her first step toward going home.

A couple of hours later, she felt a strange itch on the top of her head. She scratched reflexively. Then the recognition hit her like a slap: Not now, she thought. She grabbed the IV pole, still dripping fluids into her system, and ran out into the hallway. “I need a nurse,” she shouted. Her heart was pounding, and she knew what was coming next. Hospital staffers in scrubs descended on her. Was she having a panic attack? No, an allergy attack, she told them.

They helped her back into bed and gave her oxygen, Benadryl and steroids. “What happened?” someone asked. She told the whole story, plus something she now realized — every one of her attacks seemed to come a few hours after she ate beef. She didn’t go through this every time she had a hamburger or steak; meat was a regular and much-loved part of her diet. But she was pretty sure that she had steak — or beef brisket, this time — before each episode.

Her doctors were dubious. New food allergies — especially severe ones like hers — are uncommon in adults. This was much more likely to be an allergic response to one of the antibiotics they were giving her. The patient, though, found that theory hard to swallow. It might explain this episode, but what about the earlier ones? She hadn’t been on antibiotics then. The doctors had no answer.

Was a Tick to Blame?

A nurse had a different theory about what happened, one the patient had heard before but never believed. There was some kind of tick, the nurse told her, whose bite could make you allergic to meat. She didn’t know much about it. But, the nurse suggested, she should check it out.

The woman had been bitten by ticks before — who on Long Island hasn’t? But was it really possible for a bite to produce this crazy reaction? Indeed it was, she discovered, when she got home and began doing some research. The bite of the lone star tick — named for a white spot shaped like Texas on the arachnid’s back — could cause an allergic reaction to mammalian meat. The trigger was a sugar, identified as galactose-α-1,3-galactose and more casually known as alpha-gal, a carbohydrate found in the flesh of all nonprimate mammals.

How the tick bite triggers this allergy is not yet known. The link between the tick — whose range extends from southern Florida to Maine and as far west as Iowa — and the resulting alpha-gal allergy was first described in 2009 by Thomas Platts-Mills, a professor at the University of Virginia, who himself developed the disorder. Unlike most food allergies, in which symptoms occur within minutes of consuming the allergen, the alpha-gal reaction is delayed. The symptoms — ranging from a rash to nausea to shortness of breath and even anaphylaxis — can appear four to six hours after a meal containing meat. Stranger still, the reaction doesn’t occur after every exposure.

A Diet Changed Forever

The diagnosis of mammalian meat allergy (M.M.A.) can be confirmed with a blood test that identifies antibodies to alpha-gal. The patient contacted Diane Cymerman, an allergist she had seen years earlier for seasonal allergies. Cymerman asked her to list all the foods she consumed before her last episode in the hospital and had her blood tested for antibodies to everything on the list, down to the black pepper and parsley seasoning. And to alpha-gal.

The first results came back the following week: She had a moderate allergy to beef, but everything else was normal. The following month, the test results for alpha-gal antibodies came back. She was wildly allergic to galactose-α-1,3-galactose. Cymerman called the patient with the news. She had to avoid eating meat from mammals — and everything derived from them, including Jell-O and other foods and medications made from gelatin. Even safe foods cooked on a grill that has also been used for meat can be contaminated with enough alpha-gal to trigger a reaction.

The patient contacted the allergist back in Iowa and told him what she had. He was amazed. He had only recently heard a lecture on this phenomenon. He had never seen it before her case.

It hasn’t been easy for this Iowa transplant to give up beef and other meat that comes from mammals. Some days, she tells me, just thinking about a juicy hamburger or steak makes her stomach growl. But she remembers her terror and that long drive to the Iowa hospital and sticks to chicken, fish and vegetables.

Lisa Sanders, M.D., is a contributing writer for the magazine and the author of “Every Patient Tells a Story: Medical Mysteries and the Art of Diagnosis.” If you have a solved case to share with Dr. Sanders, write her at Lisa.Sandersmd@gmail.com.

________________

**Comment**

For more on Alpha-Gal:  http://alpha-gal.org

https://madisonarealymesupportgroup.com/2017/01/12/tick-related-red-meat-allergy-found-in-minnesota-wisconsin/

Approx. 5 Min.

Great video by Dr. Greger at nutritionfacts.org on tick bites, meat allergies, and chronic urticaria

https://madisonarealymesupportgroup.com/2016/02/05/paralysis-tick-the-immune-system/  Australian allergy specialist Sheryl van Nunen got her red meat allergy mystery solved when there was a surge in allergic reactions in the U.S. to a drug, Cetuximab, used to treat colorectal cancer developed using a mouse cell line, also containing alpha-gal.

Pause

If you haven’t read the articles on vaccines, please do.
https://madisonarealymesupportgroup.wordpress.com/2015/06/19/a-word-on-vaccines/ and https://madisonarealymesupportgroup.wordpress.com/2015/07/15/vaccines-continued/
Some vaccines used to be run through mouse brains. This is important to know as mice are one of the biggest reservoirs for borrelia, the causative agent known to cause Lyme Disease.

More damning evidence of the mouse/vaccine connection:  https://madisonarealymesupportgroup.com/2017/10/15/vaccines-and-retroviruses-a-whistleblower-reveals-what-the-government-is-hiding/

 

 

 

 

 

 

2-Tier Lyme Testing Missed 85.7% of Patients – Milford Hospital

https://www.change.org/p/1120418/u/22255324?utm_medium=email&utm_source=petition_update&utm_campaign=228977&sfmc_tk=GMMXfuEdwN9ahd2uRes%2bYz7IACkro6DA7%2brPwdqwfoMnga0JumrNDJyG2Dm49N96&j=228977&sfmc_sub=410444853&l=32_HTML&u=41890189&mid=7259882&jb=74

The 2-tier serology assay missed 85.7% of the cases of early Lyme disease with spirochetemia

Carl Tuttle
Hudson, NH
JAN 16, 2018 — Please see the letter below addressed to the TBD Working Group referencing ongoing attempts to suppress direct detection methods in the laboratory testing for Lyme disease.

Anyone wishing to contact the Lyme Disease Working Group can send an email to:  tickbornedisease@hhs.gov

Letter to the Working Group:

I would like to call attention to the study below published in November of 2010 by Dr. Sin Lee identifying faulty serology tests for Lyme disease in 85.7% of the walk-in patients in the Emergency Room of Milford Hospital.

One month after publishing his paper (Dec 13, 2010) Dr. Lee received a termination of employment letter from the Director of Human Resources at Milford Hospital as they ordered the immediate shutdown of the molecular diagnostic laboratory. It appears that individuals at Yale Medical Group weren’t happy with the truth and wanted to end his work and shut down his lab sabotaging the development of a DNA sequencing test for Lyme disease diagnosis.

For those who haven’t made the connection:

Serology cannot be used to gauge treatment failure or success which makes it the ideal tool for concealing persistent infection perpetuating the thirty year dogma that chronic Lyme does not exist.

Did the scientists in Europe use Western blot or DNA sequencing to prove the Iceman contracted Lyme disease 5000 years ago? If DNA sequencing can be used to confirm Lyme disease in a dead man frozen 5000 years ago, why are we not trying to use the same technology to diagnose Lyme disease on those still walking?

Iceman Mummy May Hold Earliest Evidence of Lyme Disease

https://www.livescience.com/18704-oldest-case-lyme-disease-spotted-iceman-mummy.html

Dr. Lee went on to win a lawsuit against his employer’s irrelevant unsubstantiated accusations(Sin Hang Lee vs. Milford Hospital, Incorporated et al) and reopened his lab to continue his work. In 2014 Dr. Lee published a study of persistent infection while working on a project with the Centers for Disease Control. Once that study was published, the CDC stopped communicating with him.

“There are people who do not want to see the ugly truth which may be revealed by widespread use of direct detection tests.”

With early detection and treatment, eradication of infection is possible but faulty/misleading antibody tests are the root cause of unimaginable pain and suffering.

A Lyme patient in Norway won her recent lawsuit due to faulty/misleading antibody tests….

“On May 23rd, 2017, Seim was granted, in the District Court, 340,000 in court costs, and claims for expenses for up to 90,000”

BOTA BORRELIA – CURE LYME – Lyme patient receives compensation 10 years after inadequate treatment.
https://botaborrelia.wordpress.com/2018/01/09/bota-borrelia-cure-lyme-borreliapatient-far-ersattning-10-ar-efter-bristande-behandling-lyme-patient-receives-compensation-10-years-after-inadequate-treatment/
___________________________

1. Dr. Lee’s 2010 Publication:

BMC Res Notes. 2010 Nov 1;3:273. doi: 10.1186/1756-0500-3-273.
Early Lyme disease with spirochetemia – diagnosed by DNA sequencing.
Lee SH1, Vigliotti VS, Vigliotti JS, Jones W, Williams J, Walshon J. https://www.ncbi.nlm.nih.gov/pubmed/21040573

Abstract

BACKGROUND:

A sensitive and analytically specific nucleic acid amplification test (NAAT) is valuable in confirming the diagnosis of early Lyme disease at the stage of spirochetemia.

FINDINGS:

Venous blood drawn from patients with clinical presentations of Lyme disease was tested for the standard 2-tier screen and Western Blot serology assay for Lyme disease, and also by a nested polymerase chain reaction (PCR) for B. burgdorferi sensu lato 16S ribosomal DNA. The PCR amplicon was sequenced for B. burgdorferi genomic DNA validation. A total of 130 patients visiting emergency room (ER) or Walk-in clinic (WALKIN), and 333 patients referred through the private physicians’ offices were studied. While 5.4% of the ER/WALKIN patients showed DNA evidence of spirochetemia, none (0%) of the patients referred from private physicians’ offices were DNA-positive. In contrast, while 8.4% of the patients referred from private physicians’ offices were positive for the 2-tier Lyme serology assay, only 1.5% of the ER/WALKIN patients were positive for this antibody test. The 2-tier serology assay missed 85.7% of the cases of early Lyme disease with spirochetemia. The latter diagnosis was confirmed by DNA sequencing.

CONCLUSION:

Nested PCR followed by automated DNA sequencing is a valuable supplement to the standard 2-tier antibody assay in the diagnosis of early Lyme disease with spirochetemia. The best time to test for Lyme spirochetemia is when the patients living in the Lyme disease endemic areas develop unexplained symptoms or clinical manifestations that are consistent with Lyme disease early in the course of their illness.
__________________________

2. Dr. Lee’s additional publication identifying chronic Lyme: (2014)

DNA sequencing diagnosis of off-season spirochetemia with low bacterial density in Borrelia burgdorferi and Borrelia miyamotoi infections.
https://www.ncbi.nlm.nih.gov/pubmed/24968274
_______________________

At what point in time do we acknowledge that Lyme disease has been tenaciously mishandled to protect the long established racketeering scheme outlined in the Shrader & Associates RICO lawsuit;

You can read the court document here:

https://www.courthousenews.com/wp-content/uploads/2017/11/LymeDisease.pdf

Might I remind everyone reading this email that the Centers for Disease Control has aligned itself with the seven defendants identified in this racketeering lawsuit so if the CDC is allowed to oversee the future direction of Lyme per the recommendations/outcome of this TBD Working Group we are in for another thirty years of failure to control, treat and eliminate this 21st Century plague.

Sincerely,

Carl Tuttle
Lyme Endemic Hudson, NH

 

New Lyme Tests Could Offer Quicker, More Accurate Detection

https://news.rutgers.edu/new-lyme-disease-tests-could-offer-quicker-more-accurate-detection/20171206#.WlzTVug-c2Y

New Lyme Disease Tests Could Offer Quicker, More Accurate Detection

Updated methods would help doctors decide when to prescribe the antibiotics used to clear the infection and help avoid severe long-term health problems
New tests are at hand that offer more accurate, less ambiguous test results that can yield actionable results in a timely fashion.
“Improved tests will allow for earlier diagnosis, which should improve patient outcomes.” – Steven Schutzer
 New tests to detect early Lyme disease – which is increasing beyond the summer months – could replace existing tests that often do not clearly identify the infection before health problems occur.

In an analysis published on December 7 in Clinical Infectious Diseases, scientists from Rutgers University, Harvard University, Yale University, the National Institute of Allergy and Infectious Diseases of the National Institutes of Health and other academic centers, industry and public health agencies say new diagnostic methods offer a better chance for more accurate detection of the infection from the Lyme bacteria.

“New tests are at hand that offer more accurate, less ambiguous test results that can yield actionable results in a timely fashion,” said Steven Schutzer, a physician-scientist at Rutgers New Jersey Medical School and senior author. “Improved tests will allow for earlier diagnosis, which should improve patient outcomes.”

Lyme disease is the most common tick-borne infection in North America and Europe. There are currently over 300,000 cases of Lyme disease annually in the United States alone, and the disease is increasing and spreading into new regions. Lyme disease frequently, but not always, presents with a bull’s-eye rash. When the rash is absent, a laboratory test is needed.

The only FDA-approved Lyme disease tests, based on technology developed more than two decades ago, rely on detecting antibodies that the body’s immune system makes in response to the disease. These antibody-based tests are the most commonly used tests for Lyme disease and are the current standard.

Lyme disease rash
Lyme disease frequently, but not always, presents with a bull’s-eye rash. When the rash is absent, a laboratory test is needed.
One problem, however, is that many people produce similar – called “cross-reactive” – antibodies in response to other bacteria not associated with Lyme disease, which causes confusing results and makes test accuracy more difficult.

“New tests are more exact and are not as susceptible to the same false-positive or false-negative results associated with current tests.” said Schutzer.

Schutzer and his colleagues say more accurate testing would help doctors decide when to prescribe the antibiotics used to clear the infection and help avoid severe long-term health problems. Antibody tests, can take three weeks or more for the antibody levels to reach a point where the tests can pick up a positive result.

Those involved in the paper joined forces after meeting at Cold Spring Harbor Laboratory’s Banbury Center, a nonprofit research institution in New York.  The meeting organized and chaired by Schutzer and John A. Branda, assistant professor of pathology at Harvard Medical School, focused on current Lyme disease tests and new scientific advances made in increasing the accuracy of the diagnosis.

“This meeting and paper resulting from it are particularly significant,” said Jan Witkowski, professor in the Watson School of Biological Sciences at Cold Spring Harbor Laboratory who along with Nobel Laureate James Watson asked Schutzer to lead several symposia. “The participants noted that there are greatly improved diagnostic tests for Lyme disease that can be implemented now, and that the way is open to the development of further tests.”

______________

**Comment**

The article fails to mention these “better tests” and the abstract fails to do so as well, except to say that next-generation serodiagnostic testing, focusing on methods that are currently available or near-at-hand, can now overcome or circumvent many of the past drawbacks.  Abstract found here:  https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/cix943/4706288?redirectedFrom=fulltext

Those of us in Lyme-land have known for decades that better testing is available, it’s just mainstream medicine refuses to use them.  I know of a patient who after testing negative on the CDC two-tiered testing, went to a Lyme literate doctor who used the extended Western Blot from IgeneX and tested positive.  When she showed up with proof in hand, the regular doctor announced that test was faulty, threw it into the trash, and then without permission, retested her again with the CDC two-tier testing.  When the patient showed up at a follow-up appointment, the doctor smugly announced she did not have Lyme because the second CDC test was again negative.

This is the type of thing Lyme/MSID patients are used to and what we advocates warn folks of.  Do not expect a regular doctor, at this point in time, to embrace any testing methods other than the CDC two-tiered testing.  They will even tell you they are FDA-approved which is only half the story.  The FDA does not require approval for labs that do not sell test kits (such as IGeneX).  There are all sorts of laboratory standards and IGeneX is a CLIA-certified high complexity testing lab with on site inspections by state and federal inspectors every two years in states that have the most stringent lab requirements (New York, and California).  They are a small lab specializing in bacteriology and virology – not a monopoly that tests for everything from staph to strep.

Go here for IGeneX accreditations, certifications, and licenses:  https://www.igenex.com/why-igenex/licenses-accreditations/  You can print these out and attempt to show your general GP; however, I wouldn’t hold my breath despite the concrete evidence.

Rivoting here a moment, I remember attending a public forum at the WI capital where a pediatric doctor called the IGeneX test, “Home brewed,” obviously deriving that particular wording from here:  https://www.igenex.com/why-igenex/licenses-accreditations/

I assure you, CLIA has tough standards and would not allow a lab to exist if it didn’t cut the muster.  The problem, once again, is that doctors are woefully uneducated and fall back on quick articles like these to pass judgement, rather than studying the issue for themselves.  This lack of due diligence has unfortunately affected thousands of people who are sent home and denied treatment due to a negative test.  

Lyme patients and advocates have been screaming bloody murder for years over the conflicts of interest and CDC testing monopoly.  Go here for the sordid story:  https://crymedisease.wordpress.com/2016/02/28/the-conspirators-they-own-the-patents-and-changed-the-testing/   (spoiler alert – they own the patents to the tests)

http://truthbetoldx81.blogspot.com/2017/06/biggest-medical-fraud-in-history-of.html

https://on-lyme.org/en/sufferers/lyme-stories/item/261-unprecedented-claim-against-the-cdc-over-lyme-tests   The CDC commitment to the national study abruptly stopped with no reasons given. However, it appears the CDC is focusing on developing their own newly patented test rather than supporting a group of innovators that compete with the CDC patents.

https://madisonarealymesupportgroup.com/wp-content/uploads/2018/01/09bc3-uos2_claim_references_2.pdf  The CDC denies patent holding despite it being right here in purple crayon.

In conclusion and purposely focusing on the silver lining, this article will hopefully poke the scientific world from its 40 year nap and be a reminder that the outcome of the most prevalent vector-borne disease on the planet has been stymied by a lack of diagnostic testing and that more accurate testing is required.  

Hopefully it will also begin the breakup of the love-affair the CDC has for two-tiered testing.

For more on testing:

https://www.lymedisease.org/lyme-basics/lyme-disease/diagnosis/

https://madisonarealymesupportgroup.com/2016/12/07/igenex-presentation/

https://madisonarealymesupportgroup.com/2017/10/17/igenex-introduces-3-new-lyme-tests/

https://madisonarealymesupportgroup.com/2017/08/15/reliability-of-lyme-testing/

https://madisonarealymesupportgroup.com/2017/04/12/comparing-lyme-testing-with-hiv-testing/